Objective The aim of the present systematic review and metaanalysis was to assess the clinical efficacy of regenerative periodontal surgery of intrabony defects using a combination of enamel matrix derivative (EMD) and bone graft compared with that of EMD alone. Materials and methods The Cochrane Oral Health Group specialist trials, MEDLINE, and EMBASE databases were searched for entries up to February 2014. The primary outcome was gain of clinical attachment (CAL). Weighted means and forest plots were calculated for CAL gain, probing depth (PD), and gingival recession (REC). Results Twelve studies reporting on 434 patients and 548 intrabony defects were selected for the analysis. Mean CAL gain amounted to 3.76±1.07 mm (median 3.63 95 % CI 3.51-3.75) following treatment with a combination of EMD and bone graft and to 3.32±1.04 mm (median 3.40; 95 % CI 3.28-3.52) following treatment with EMD alone. Mean PD reduction measured 4.22±1.20 mm (median 4.10; 95 % CI 3.96-4.24) at sites treated with EMD and bone graft and Clinical relevance The present findings support the use of EMD and bone grafts for the treatment of intrabony periodontal defects.
Introduction
Periodontitis is an infectious disease triggered by periodontal pathogenic bacteria and is characterized by pocket formation and attachment loss, ultimately affecting tooth survival [1] . Besides the anti-infectious therapy aiming to eliminate or reduce the periodontal pathogenic flora in order to arrest the destruction process, one important goal is to reconstruct the bone defects caused by the infectious process [2, 3] . During the last decades, various treatment modalities such as the use of different bone grafting materials, guided tissue regeneration (GTR), enamel matrix derivative (EMD), or combinations thereof have been used to predictably regenerate the lost tooth's supporting tissues including root cementum, periodontal ligament, alveolar bone, and gingiva [2, 3] . Narrative and systematic reviews have provided evidence indicating that the use of EMD in conjunction with open flap debridement (OFD) significantly improved the clinical outcomes in intrabony defects compared with OFD alone [4] [5] [6] . In several studies [7] [8] [9] [10] , it was recognized that the morphology of the osseous defect plays an important role in the healing capacity of the defect itself. For example, in the presence of non-contained defects, the use of a non-resorbable titanium-reinforced membrane or the combination of a resorbable membrane with a grafting material has been advocated [11] . It has been also shown that the use of biomaterials without space-making properties such as EMD may not be sufficient for the treatment of deep non-contained intrabony defects. In fact, the results of a clinical study using EMD alone for the treatment of intrabony defects [12] showed that threewall defects yielded a 2.7 times higher probability of gaining at least 3 mm of CAL compared with those of one-wall defects. In a randomized controlled clinical trial, the application of a non-resorbable titanium-reinforced membrane increased by seven times the probability of obtaining a significant CAL gain of at least 4 mm compared with the application of EMD alone in the treatment of non-contained intrabony defects [13] . Therefore, in order to maximize the clinical outcomes by stabilizing the blood clot and preventing flap collapse, the combination of EMD and bone grafts has been proposed [14, 15] .
Results from a recent series of studies evaluating EMD adsorption to the surface of various types of bone grafts such as a demineralized bovine bone mineral (DBBM) have shown that this combination can stimulate the release of growth factors and cytokines including bone morphogenetic protein 2 and transforming growth factor beta 1. Moreover, there were significantly higher mRNA levels of osteoblast differentiation markers including collagen1α1, alkaline phosphatase, and osteocalcin in osteoblasts and PDL cells cultured on EMDcoated DBBM particles thus suggesting that EMD enhances osteoblast and PDL cell attachment, proliferation, and differentiation on DBBM particles and provides a biologic rationale for using this combination in regenerative periodontal therapy [16] . Thus, the available clinical and biological data appear to support the combination of EMD and bone grafts for regenerative treatment in intrabony defects. It is also anticipated that this combination may even yield synergistic effects where the graft material may act as an osteoconductive scaffold maintaining in the same time the defect space, while EMD may induce formation of root cementum, periodontal ligament, and bone [14] [15] [16] .
Despite the fact that in recent years, different combinations of EMD and bone grafts including autogenous bone [17] [18] [19] , demineralized freeze dried bone allograft (DFDBA) [20] [21] [22] , DBBM [23] [24] [25] [26] [27] [28] [29] [30] , and alloplastic materials [31-37] have been used to regenerate intrabony defects; the outcomes showed great variability. Thus, at the time being, it is still unclear to what extent the combination of EMD and different graft materials may lead to additional clinical improvements compared to the use of EMD alone. At present, according to the best of our knowledge, no data from systematic reviews including meta-analysis are available, and thus, the magnitude of the clinical improvements that can be obtained following the combination approach over the use of EMD alone is still unclear. Therefore, the aim of the present systematic review and meta-analysis was to assess the clinical efficacy of regenerative periodontal surgery in intrabony defects using a combination of EMD and bone grafts compared with the application of EMD alone.
Materials and methods
This systematic review was prepared by following the recommendations by Needleman et al. [38] and the PRISMA principles (Preferred Reporting Items for Systematic Reviews and Meta-analysis) [39] .
Focused question
The focused question was formulated according to the population intervention control outcome (PICO) principle BIn patients with intrabony defects, what are the clinical benefits of using a combination of enamel matrix derivative (EMD) and bone graft compared with EMD alone.Ŝ
earch strategy
The search was conducted on electronic databases up to February 2014. The search was applied to the Cochrane Oral Health Group specialist trials, MEDLINE, and EMBASE.
The 
Inclusion criteria
The studies were included on the basis of the following criteria: 
Data extraction and analysis
The titles identified by the search were screened independently by two reviewers (M.M. and V.I.S.). The abstracts of all studies of possible relevance were obtained and screened independently by the reviewers. When studies met the inclusion criteria or when insufficient data from abstracts were available to evaluate inclusion criteria, the full-text article was obtained. The selected papers were screened independently by the reviewers to confirm whether they met the inclusion criteria or not. The inter-examiner agreement was analyzed by kappa coefficient. Any discrepancy between the two reviewers was resolved via discussion. Data were extracted independently by the two examiners (M.M. and V.I.S.). If the reviewers had data-related questions, the authors of the selected papers were contacted.
Outcome measures
The primary outcome measure (i.e., true endpoint outcome) included 
Methodological quality assessment
With respect to randomized controlled trials (RCTs) and controlled clinical trials (CCTs), quality assessment was performed by means of the Cochrane Collaboration's tool for assessing risk of bias (www.cochrane-handbook.org).
Data analysis
Study outcomes are reported by means of evidence tables and a quantitative synthesis by means of a meta-analysis.
For data analysis, EpiDat software (EpiDat version 3.1 for Windows, Dirección Xeral de Innovación e Xestión da Saúde Pública de Galicia-Spain) was used. Mean differences and 95 % confidence intervals of differences (95 % CI) were calculated for PD, CAL, and REC. Statistical heterogeneity was evaluated by DerSimonian-Laird's test, where p values below 0.05 were considered heterogeneous. The degree of inconsistency was verified by the I^2 test. An analysis by sub-groups was performed considering the different grafts associated with EMD using the random effect model due to the heterogeneity detected. The forest plot was utilized to illustrate the weighted mean of the outcome in each study and the final estimate.
Results
From an original yield of 12,288 titles and 152 abstracts, 15 studies were selected for the full-text analysis. Three studies were excluded, and a total of 12 studies were selected for the analysis (Fig. 1) . Reasons for exclusion are summarized in Table 1 . One study [35] was excluded because it reported only 6-month results and the same data were used in another publication with a follow-up of 1 year [36] . Two studies [33, 37] were excluded because an observation time of 4 years was reported.
Study characteristics
The summary of quality assessment is described in Table 2 . In the randomized controlled clinical trials, four studies [19, 23, 26 , 34] had a high risk of bias.
Descriptive data relative to the included 12 studies are reported in Table 3 . Only one study was not specifically designed to test the combination of EMD and bone graft compared with EMD alone [30], whereas for the other studies, data were extracted from the original samples. All studies were randomized controlled clinical trials (RCTs). In ten studies, a simple randomization was performed, whereas only in two studies [28, 30] , a balanced block randomization was done. Eight studies were single-blinded [14, 18, 26, 28, 32, 34 , 36]; one was double-blind [23] , whereas in only one study, the masking was not performed [19] and in two studies, these data were not available [30, 31] . In all studies, a power calculation was performed with the exception of three studies [20, 23, 36] . Two studies were conducted in private practice [14, 30] , whereas one study was conducted both in private practice and in university [28] . Outcomes of other studies were not reported. Six different types of intervention were tested: in four studies, a combination of EMD and DBBM was analyzed [23, 26, 28, 30] ; two studies were conducted using a combination of EMD and autologous bone graft [18, 19] , while two studies tested a combination of EMD and Bioglass [31, 32] . A combination of hydroxyapatite and β-tricalcium phosphate (HA + β-TCP) was used in two publications [14, 36] . The combination of EMD and DFDBA was tested in two studies [20, 21] , while that of EMD and β-TCP was evaluated in one study [34] . The follow-up period varied between the studies (i.e., 6 months in two studies [20, 23] , from 6 to 8 months in one study [26] , 8 months in one study [32] , 12 months in seven studies [18, 19, 28, 30, 31, 34 , 36], 24 months in one study [14] ).
Patient's characteristics
The studies reported a total of 434 patients (189 males and 245 females) with an age range between 19 and 76 years. Sixty- eight patients were tobacco smokers. Only one paper did not report smoking habits [20] . Five dropouts were reported in three studies [14, 34, 36] . Patients enrolled in four studies suffered from chronic periodontitis [18, 28, 32, 36] , whereas in one study, patients were suffering from chronic and aggressive periodontitis [19] and in another study, periodontitis was defined as moderate to advanced [26] . The other paper did not report about periodontal status (Table 4) .
Tooth and defect characteristics at baseline
The studies reported a total of 548 teeth with different morphology of intrabony defects (one defect per tooth). In four papers one-, two-, and three-wall intrabony defects were treated [20, 30, 31, 34] , whereas in three publications, two-and three-wall defects were selected [18, 23, 26] . Four studies focused on one-to two-wall defects [14, 19, 32, 36] . In only one study, the data about defect morphology was not available [28] . The percentage of sites with BoP+ was recorded only in three publications [18, 31, 34] (Table 5) .
Clinical and intrasurgical characteristics of defects at baseline Table 6 illustrates baseline characteristics of the included defects, surgical approach performed, and the use of systemic [18] . Systemic antibiotics were not prescribed in one study [30] , whereas in two papers, these data were not reported [31, 36] (Table 6) .
Changes in BOP, PD, CAL, and REC
In 
Tooth survival rates and complications
Survival rate and complications are presented in Table 8 . No tooth was lost during the follow-up, and the survival rate was 100 %. In eight studies, flap dehiscences were not noted [20, 23, 26, 28, [30] [31] [32] 34 ], whereas in the other studies, these data are not available for the analysis. Only three studies reported data about primary wound healing of interdental space [14, 30, 34] . The outcomes related to the number of residual pocket depth ≥5 mm are not available for the analysis. In one study, one site with attachment loss was recorded [31], while no attachment loss was noted in three publications [19, 30, 34] . These data were not available for analysis in the other studies.
Discussion
The present systematic review has evaluated the efficacy of combining EMD and bone grafts compared with the use of EMD alone in the treatment of periodontal intrabony based on existing RCTs. The outcomes indicate that treatment of periodontal intrabony defects using a combination of EMD and bone grafts appears to represent a predictable treatment modality. Unfortunately, there are few well-designed clinical studies evaluating the efficacy of these regenerative surgical protocols. The primary outcome variable selected was the CAL change after a mean follow-up period varying from 6 to 24 months. The evaluation period of 6 to 24 months was selected, due to the fact that this is the time frame used in most clinical studies to evaluate the outcomes of reconstructive periodontal surgery. The findings from the meta-analysis have demonstrated significantly better CAL gain and PD reduction in the defects treated with EMD and bone grafts when compared with the healing of the defects treated using EMD alone. Hence, the outcomes from the meta-analysis suggest that the use of EMD with bone graft improves better results in terms of CAL gain and PD reduction. These data are in agreement with a recent narrative review, which has assessed the biologic rationale and potential clinical benefit of a combination EMD and bone grafts in the treatment of deep intrabony defects [40] . The authors concluded that although a clinical benefit of the combination approach was observed, direct evidence supporting this concept is still missing and further controlled clinical trials are required to explain the large variability that exists among the selected studies. However, the results of the present systematic review must be interpreted with caution. First of all, it should be kept in mind that in this meta-analysis, the outcomes of regenerative surgery performed in defects with different types of morphology (i.e., one-, two-, and three-walled and combinations thereof), using different types of grafts and surgical techniques, have been combined. Secondly, the lack of consistency and standardization may have contributed to the high heterogeneity of the results. Furthermore, due to the lack of data, no meta-analysis could be performed on defect morphology and surgical flap designs, which are well known factors influencing the outcomes following regenerative therapy [11, 12] . In many studies selected for the final analysis, the data about the management of interdental papilla and the primary wound closure during early wound healing was not reported. While in most studies, a conventional flap was performed; in two studies [30, 34] , a minimally surgical approach was used. Those two studies reported CAL gains of 4.0 ±1.0 mm and 3.7±1.3 mm, but the microsurgical approach did not seem to influence the healing. Interestingly, the data reported in these two studies are in agreement with the outcomes reported in the other studies included in the present meta-analysis. CAL change (mm) Fig. 3 Forest plot from fixed effects of meta-analysis evaluating the differences in CAL gain (in mm) after surgical treatment using EMD and bone graft or EMD alone (weighted mean difference, 95 % CI) Fig. 2 Forest plot from fixed effects of meta-analysis evaluating the differences in PD reduction (in mm) after surgical treatment using EMD and bone graft or EMD alone (weighted mean difference, 95 % CI)
Despite the fact that tooth survival rate was 100 % using both regenerative approaches, none of the studies reported on the outcomes in terms of residual pockets ≥5 mm. Furthermore, in most studies, no data on sites with attachment loss following regenerative surgery were recorded. In three papers [19, 30, 34] , no sites with attachment loss were recorded, while only one paper mentioned [31] one site with attachment loss.
An interesting finding of the present meta-analysis was the statistically significantly better outcome in terms of REC increase following treatment with EMD alone. While the biological or clinical background for this finding is a matter of Fig. 4 Forest plot from fixed effects of meta-analysis evaluating the differences in REC increase (in mm) after surgical treatment using EMD and bone graft or EMD alone (weighted mean difference, 95 % CI) 
Conclusion
Within their limits, the present results indicate that the combination of EMD and bone grafts may result in additional clinical improvements in terms of CAL gain and PD reduction compared with those obtained with EMD alone. The potential influence of the chosen graft material or of the surgical procedure (i.e., flap design) on the clinical outcomes is unclear.
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